Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. 詳細を表示
CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
-- Presented initial in vivo data for universal liver-targeted LNP and Wilson’s Disease program at ESGCT; initiated IND-enabling activities for Wilson’s Disease program in 4Q 2024 and remains on...
CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.5201 | -15.4791666667 | 3.36 | 3.59 | 2.765 | 952501 | 3.1694228 | CS |
4 | -0.0701 | -2.4089347079 | 2.91 | 3.59 | 2.56 | 1188683 | 2.9325556 | CS |
12 | -1.4601 | -33.9558139535 | 4.3 | 4.71 | 2.56 | 1141570 | 3.38028987 | CS |
26 | -2.8901 | -50.4380453752 | 5.73 | 6.75 | 2.56 | 1245850 | 3.78420698 | CS |
52 | -4.6901 | -62.2855245684 | 7.53 | 9.77 | 2.56 | 1022758 | 4.85676814 | CS |
156 | -16.1301 | -85.0295202952 | 18.97 | 21.7301 | 2.56 | 655620 | 7.16713575 | CS |
260 | -16.1301 | -85.0295202952 | 18.97 | 21.7301 | 2.56 | 655620 | 7.16713575 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約